Biggest News Aggregation in the World
📰 Opgn News

Opgn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Opgn. Real-time updates on events, politics, business and more.

OpGen (NASDAQ:OPGN) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.47 on Wednesday. The company’s 50-day simple moving average is $0.57 and its 200-day simple moving […]
United States Gene Panel Exchange Commission Opgen Inc Chase Investment Counsel Corp Free Report
Source: wkrb13.com

OpGen (NASDAQ:OPGN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Down 3.1 % OPGN opened at $0.47 on Wednesday. The company has a market capitalization of $5.93 million, a price-to-earnings ratio […]
United States Chase Investment Counsel Corp Securities Exchange Commission Opgen Inc Opgen Company Profile Gene Panel

Short Interest in OpGen, Inc. (NASDAQ:OPGN) Expands By 10,621.2%

OpGen, Inc. (NASDAQ:OPGN – Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 2,230,000 shares, an increase of 10,621.2% from the March 15th total of 20,800 shares. Based on an average daily trading volume, of 1,670,000 shares, the short-interest ratio is currently 1.3 […]
United States Vanguard Group Inc Gene Panel Dimensional Fund Advisors Opgen Inc Citadel Advisors
Source: wkrb13.com

OpGen, Inc. (NASDAQ:OPGN) Sees Large Decrease in Short Interest

OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 20,800 shares, a drop of 47.3% from the February 29th total of 39,500 shares. Based on an average daily trading volume, of 1,470,000 shares, the short-interest ratio […]
United States Opgen Company Profile Citadel Advisors Opgen Inc Vanguard Group Inc Gene Panel

OpGen (NASDAQ:OPGN) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical research company’s stock. OpGen Stock Up 4.8 % OPGN traded up $0.02 on Thursday, hitting $0.35. 81,961 shares of the […]
United States Gene Panel Opgen Inc Citadel Advisors Vanguard Group Inc Dimensional Fund Advisors
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN)

Research analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical research company’s stock. OpGen Stock Performance OpGen stock opened at $0.39 on Wednesday. OpGen has a fifty-two week low of […]
United States Dimensional Fund Advisors Opgen Inc Gene Panel Citadel Advisors Opgen Company Profile

OpGen (NASDAQ:OPGN) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the medical research company’s stock. OpGen Trading Down 2.3 % Shares of NASDAQ:OPGN opened at $0.42 on Tuesday. OpGen has a 12-month […]
United States Citadel Advisors Dimensional Fund Advisors Vanguard Group Inc Opgen Inc Gene Panel

OpGen (NASDAQ:OPGN) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Monday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Down 2.9 % NASDAQ:OPGN opened at $0.42 on Monday. The stock has a market cap of $4.16 million, a P/E ratio of […]
United States Gene Panel Opgen Inc Dimensional Fund Advisors Vanguard Group Inc Citadel Advisors

OpGen (NASDAQ:OPGN) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Monday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN stock opened at $0.42 on Monday. The firm’s 50 day moving average price is $0.49 and its 200-day […]
United States Opgen Inc Dimensional Fund Advisors Opgen Company Profile Vanguard Group Inc Gene Panel

OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Price Performance Shares of NASDAQ:OPGN opened at $0.45 on Friday. OpGen has a 1-year low of $0.17 and a 1-year high of $3.84. The […]
United States Gene Panel Citadel Advisors Vanguard Group Inc Dimensional Fund Advisors Opgen Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science